Sze Wah Samuel Chan

Subtypes of EGFR- and HER2-Mutant Metastatic NSCLC Influence Response to Immune Checkpoint Inhibitors

Sally C. M. Lau, Aline Fusco Fares, Lisa W. Le et al. · Clinical Lung Cancer · 2021 · 63 citations

Medicine, Immune Checkpoint Inhibitors, Immunology +6

New trends in corneal transplants at the University of Toronto

Sze Wah Samuel Chan, Yeni H. Yücel, Neeru Gupta · Canadian Journal of Ophthalmology · 2018 · 51 citations · Full text

Structural insights into the Escherichia coli lysine decarboxylases and molecular determinants of interaction with the AAA+ ATPase RavA

Eaazhisai Kandiah, Diego Carriel, Julien Pérard et al. · Scientific Reports · 2016 · 43 citations · Full text

S4-8: First results of AVEREL, a randomized phase III trial to evaluate bevacizumab (BEV) in combination with trastuzumab (H) + docetaxel (DOC) as first-line therapy for HER2−positive locally recurrent/metastatic breast cancer (LR/mBC)

Luca Gianni, Gilles Romieu, M. Lichinitser et al. · Cancer Research · 2011 · 38 citations

First-line Therapy, Breast Oncology, Cancer Management +18

Assembly principles of a unique cage formed by hexameric and decameric E. coli proteins

Hélène Malet, Kaiyin Liu, M. El Bakkouri et al. · eLife · 2014 · 23 citations · Full text